An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: New challenges for the present and the future

Expert Review of Anti-Infective Therapy

Volumn 13, Issue 2, 2015, Pages 249-265

  Rodríguez Pardo, Dolors ^a   Pigrau, Carles ^a   Corona, Pablo S ^a   Almirante, Benito ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

acute periprosthetic joint infection; antibiotic treatment; debridement; fluoroquinolones; rifampin

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; CARBAPENEM; CEFADROXIL; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DAPTOMYCIN; ERTAPENEM; FLUCLOXACILLIN; FUSIDIC ACID; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; NAFCILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; RIFAMPICIN; TEICOPLANIN; UNINDEXED DRUG; VANCOMYCIN;

ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTHROSCOPIC DEBRIDEMENT; BONE MARROW TOXICITY; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE CLASSIFICATION; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HUMAN; INFECTION CONTROL; JOINT PROSTHESIS; LIVER TOXICITY; MONOTHERAPY; NEURITIS; NONHUMAN; PATIENT SELECTION; PERIPROSTHETIC JOINT INFECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SURGICAL TECHNIQUE; TENDINITIS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT INDICATION; WOUND IRRIGATION; ACUTE DISEASE; BIOFILM; DEBRIDEMENT; DEVICE REMOVAL; DRUG EFFECTS; JOINT; PROSTHESIS-RELATED INFECTIONS;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BIOFILMS; DEBRIDEMENT; DEVICE REMOVAL; FLUOROQUINOLONES; HUMANS; JOINTS; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN;

EID: 84937141124     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2015.999669     Document Type: Review

References (154)

1. Peel TN, Cheng AC, Lorenzo YP, et al. Factors influencing the cost of prosthetic joint infection treatment. J Hosp Infect 2013;85:213-19
2. McPherson EJ, Tontz W Jr, Patzakis M, et al. Outcome of infected total knee utilizing a staging system for prosthetic joint infection. Am J Orthop 1999;28:161-5
3. McPherson EJ, Woodson C, Holtom P, et al. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res 2002;403:8-15
4. Tsukayama DT, Goldberg VM, Kyle R. Diagnosis and management of infection after total knee arthroplasty. J Bone Joint Surg Am 2003;85(A (Suppl 1)):S75
5. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004;351:1645-54
6. Zimmerli W. Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol 2006;20:1045-63
7. Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev 2014;27: 302-45
8. Berbari EF, Osmon DR, Lahr B, et al. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol 2012;33:774-81
9. Namba RS, Inacio MC, Paxton EW. Risk factors associated with surgical site infection in 30,491 primary total hip replacements. J Bone Joint Surg Br 2012;94:1330-8
10. Namba RS, Inacio MC, Paxton EW. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am 2013;95:775-82
11. Peel TN, Cheng AC, Choong PF, Buising KL. Early onset prosthetic hip and knee joint infection: treatment and outcomes in Victoria, Australia. J Hosp Infect 2012;82:248-53
12. Cobo J, Miguel LG, Euba G, et al. Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy. Clin Microbiol Infect 2011;17:1632-7
13. Kim YH, Choi Y, Kim JS. Treatment based on the type of infected TKA improves infection control. Clin Orthop Relat Res 2011;469:977-84
14. Phillips JE, Crane TP, Noy M, et al. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 2006;88:943-8
15. Soriano A, Garcia S, Bori G, et al. Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 2006;12:930-3
16. Westberg M, Grogaard B, Snorrason F. Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years. Acta Orthop 2012;83:227-32
17. Puig-Verdie L, Alentorn-Geli E, Gonzalez-Cuevas A, et al. Implant sonication increases the diagnostic accuracy of infection in patients with delayed, but not early, orthopaedic implant failure. Bone Joint J 2013;95-B:244-9
18. Lora-Tamayo J, Murillo O, Iribarren JA, et al. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis 2013;56: 182-94
19. Rodriguez-Pardo D, Pigrau C, Lora-Tamayo J, et al. Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect 2014. [Epub ahead of print]
20. Tornero E, Senneville E, Euba G, et al. Characteristics of prosthetic joint infections due to Enterococcus sp and predictors of failure: a multi-national study. Clin Microbiol Infect 2014. [Epub ahead of print]
21. Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 2005 (437):7-11
22. Aboltins C, Dowsey MM, Peel T, et al. Early prosthetic hip joint infection treated with debridement, prosthesis retention and biofilm-active antibiotics: functional outcomes, quality of life and complications. Intern Med J 2013;43:810-15
23. Aboltins CA, Dowsey MM, Buising KL, et al. Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone. Clin Microbiol Infect 2011;17:862-7
24. Achermann Y, Stasch P, Preiss S, et al. Characteristics and treatment outcomes of 69 cases with early prosthetic joint infections of the hip and knee. Infection 2014;42:511-19
25. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 1998;80:1306-13
26. Krause R, Hoenigl M, Valentin T, Zollner-Schwetz I. Debridement, antibiotic therapy, and implant retention in Staphylococcus aureus prosthetic joint infections. Clin Infect Dis 2013;56:1842-3
27. Marculescu CE, Berbari EF, Hanssen AD, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006;42:471-8
28. Martinez-Pastor JC, Munoz-Mahamud E, Vilchez F, et al. Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis. Antimicrob Agents Chemother 2009;53: 4772-7
29. Meehan AM, Osmon DR, Duffy MC, et al. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 2003;36: 845-9
30. Peel TN, Buising KL, Dowsey MM, et al. Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy. Antimicrob Agents Chemother 2013;57:350-5
31. Vilchez F, Martinez-Pastor JC, Garcia-Ramiro S, et al. Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin Microbiol Infect 2011;17:439-44
32. Kuiper JW, Vos SJ, Saouti R, et al. Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients. Acta Orthop 2013;84:380-6
33. Berdal JE, Skramm I, Mowinckel P, et al. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 2005;11:843-5
34. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs 2005;28: 1062-8
35. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996;78:512-23
36. Fehring TK, Odum SM, Berend KR, et al. Failure of irrigation and debridement for early postoperative periprosthetic infection. Clin Orthop Relat Res 2013;471:250-7
37. Cobo J, Del Pozo JL. Prosthetic joint infection: diagnosis and management. Expert Rev AntiInfect Ther 2011;9:787-802
38. Legout L, Senneville E. Periprosthetic joint infections: clinical and bench research. ScientifiWorldJournal 2013; 549091
39. Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis 2013;56:e1-e25
40. Shuman EK, Urquhart A, Malani PN. Management and prevention of prosthetic joint infection. Infect Dis Clin North Am 2012;26:29-39
41. Tattevin P, Cremieux AC, Pottier P, et al. Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis 1999;29:292-5
42. Hsieh PH, Lee MS, Hsu KY, et al. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis 2009;49:1036-43
43. Bradbury T, Fehring TK, Taunton M, et al. The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty 2009;24:101-4
44. Deirmengian C, Greenbaum J, Stern J, et al. Open debridement of acute gram-positive infections after total knee arthroplasty. Clin Orthop Relat Res 2003 (416):129-34
45. Estes CS, Beauchamp CP, Clarke HD, Spangehl MJ. A two-stage retention debridement protocol for acute periprosthetic joint infections. Clin Orthop Relat Res 2010;468:2029-38
46. Fukagawa S, Matsuda S, Miura H, et al. High-dose antibiotic infusion for infected knee prosthesis without implant removal. J Orthop Sci 2010;15:470-6
47. Kuiper JW, Brohet RM, Wassink S, et al. Implantation of resorbable gentamicin sponges in addition to irrigation and debridement in 34 patients with infection complicating total hip arthroplasty. Hip Int 2013;23:173-80
48. Tintle SM, Forsberg JA, Potter BK, et al. Prosthesis retention, serial debridement, and antibiotic bead use for the treatment of infection following total joint arthroplasty. Orthopedics 2009;32:87
49. Choong PF, Dowsey MM, Carr D, et al. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin based regimen. Acta Orthop 2007;78:755-65
50. Mont MA, Waldman B, Banerjee C, et al. Multiple irrigation, debridement, and retention of components in infected total knee arthroplasty. J Arthroplasty 1997;12: 426-33
51. Dixon P, Parish EN, Cross MJ. Arthroscopic debridement in the treatment of the infected total knee replacement. J Bone Joint Surg Br 2004;86:39-42
52. Waldman BJ, Hostin E, Mont MA, Hungerford DS. Infected total knee arthroplasty treated by arthroscopic irrigation and debridement. J Arthroplasty 2000;15:430-6
53. Hansen E, Tetreault M, Zmistowski B, et al. Outcome of one-stage cementless exchange for acute postoperative periprosthetic hip infection. Clin Orthop Relat Res 2013;471:3214-22
54. Deirmengian C, Greenbaum J, Lotke PA, et al. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J Arthroplasty 2003;18:22-6
55. Gardner J, Gioe TJ, Tatman P. Can this prosthesis be saved?: implant salvage attempts in infected primary TKA. Clin Orthop Relat Res 2011;469:970-6
56. Sherrell JC, Fehring TK, Odum S, et al. The Chitranjan Ranawat Award: fate of two-stage reimplantation after failed irrigation and debridement for periprosthetic knee infection. Clin Orthop Relat Res 2011;469:18-25
57. Koyonos L, Zmistowski B, Della Valle CJ, Parvizi J. Infection control rate of irrigation and debridement for periprosthetic joint infection. Clin Orthop Relat Res 2011;469: 3043-8
58. Anagnostakos K, Schmitt C. Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention? World J Orthop 2014;5:218-24
59. Romano C, Logoluso N, Drago L, et al. Role for irrigation and debridement in periprosthetic infections. J Knee Surg 2014;27:267-72
60. Romano CL, Manzi G, Logoluso N, Romano D. Value of debridement and irrigation for the treatment of peri-prosthetic infections. A systematic review. Hip Int 2012;22(Suppl 8):S19-24
61. Parvizi J, Gehrke T, Chen AF. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J 2013;95-B:1450-2
62. Haasper C, Buttaro M, Hozack W, et al. Irrigation and debridement. J Orthop Res 2014;32(Suppl 1):S130-5
63. Buller LT, Sabry FY, Easton RW, et al. The preoperative prediction of success following irrigation and debridement with polyethylene exchange for hip and knee prosthetic joint infections. J Arthroplasty 2012;27:857-64
64. Schoifet SD, Morrey BF. Treatment of infection after total knee arthroplasty by debridement with retention of the components. J Bone Joint Surg Am 1990;72:1383-90
65. Wolcott RD, Rumbaugh KP, James G, et al. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care 2010;19:320-8
66. Azzam KA, Seeley M, Ghanem E, et al. Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited. J Arthroplasty 2010;25:1022-7
67. Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997;24:914-19
68. Hsieh PH, Huang KC, Shih HN. Prosthetic joint infection in patients with rheumatoid arthritis: an outcome analysis compared with controls. PLoS One 2013;8:e71666
69. Byren I, Bejon P, Atkins BL, et al. One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009;63:1264-71
70. Evangelopoulos DS, Stathopoulos IP, Morassi GP, et al. Sonication: a valuable technique for diagnosis and treatment of periprosthetic joint infections. ScientificWorldJournal 2013;375140
71. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007;357:654-63
72. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002;8:881-90
73. Giulieri SG, Graber P, Ochsner PE, Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004;32:222-8
74. Odum SM, Fehring TK, Lombardi AV, et al. Irrigation and debridement for periprosthetic infections: does the organism matter? J Arthroplasty 2011;26:114-18
75. Crowley DJ, Kanakaris NK, Giannoudis PV. Irrigation of the wounds in open fractures. J Bone Joint Surg Br 2007;89:580-5
76. Anglen JO. Comparison of soap and antibiotic solutions for irrigation of lower-limb open fracture wounds. A prospective, randomized study. J Bone Joint Surg Am 2005;87:1415-22
77. Conroy BP, Anglen JO, Simpson WA, et al. Comparison of castile soap, benzalkonium chloride, and bacitracin as irrigation solutions for complex contaminated orthopaedic wounds. J Orthop Trauma 1999;13:332-7
78. Kaysinger KK, Nicholson NC, Ramp WK, Kellam JF. Toxic effects of wound irrigation solutions on cultured tibiae and osteoblasts. J Orthop Trauma 1995;9:303-11
79. Lineaweaver W, McMorris S, Soucy D, Howard R. Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg 1985;75:394-6
80. Antevil JL, Muldoon MP, Battaglia M, Green R. Intraoperative anaphylactic shock associated with bacitracin irrigation during revision total knee arthroplasty. A case report. J Bone Joint Surg Am 2003;85-A: 339-42
81. Roth RM, Gleckman RA, Gantz NM, Kelly N. Antibiotic irrigations. A plea for controlled clinical trials. Pharmacotherapy 1985;5:222-7
82. Muñoz-Mahamud E, Garcia S, Bori G, et al. Comparison of a low-pressure and a high-pressure pulsatile lavage during debridement for orthopaedic implant infection. Arch Orthop Trauma Surg 2011;131:1233-8
83. Flow Investigators. Fluid lavage of open wounds (FLOW): design and rationale for a large, multicenter collaborative 2 x 3 factorial trial of irrigating pressures and solutions in patients with open fractures. BMC Musculoskelet Disord 2010;11:85
84. Owens BD, White DW, Wenke JC. Comparison of irrigation solutions and devices in a contaminated musculoskeletal wound survival model. J Bone Joint Surg Am 2009;91:92-8
85. Whiteside LA, Nayfeh TA, LaZear R, Roy ME. Reinfected revised TKA resolves with an aggressive protocol and antibiotic infusion. Clin Orthop Relat Res 2012; 470(1):236-43
86. Corona PS, Espinal L, Rodriguez-Pardo D, et al. Antibiotic susceptibility in gram-positive chronic joint arthroplasty infections: increased aminoglycoside resistance rate in patients with prior aminoglycoside-impregnated cement spacer use. J Arthroplasty 2014;29:1617-21
87. Parvizi J, Cavanaugh PK, Diaz-Ledezma C. Periprosthetic knee infection: ten strategies that work. Knee Surg Relat Res 2013;25: 155-64
88. Cooper HJ, Della Valle CJ. The two-stage standard in revision total hip replacement. Bone Joint J 2013;95-B(11 Suppl A):84-7
89. Gehrke T, Zahar A, Kendoff D. One-stage exchange: it all began here. Bone Joint J 2013;95-B(11 Suppl A):77-83
90. Lichstein P, Gehrke T, Lombardi A, et al. One-stage versus two-stage exchange. J Orthop Res 2014;32(Suppl 1):S141-6
91. Masters JP, Smith NA, Foguet P, et al. A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord 2013;14:222
92. Wongworawat MD. Clinical faceoff: one-versus two-stage exchange arthroplasty for prosthetic joint infections. Clin Orthop Relat Res 2013;471:1750-3
93. Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 2006;66:1089-105
94. Sendi P, Zimmerli W. Antimicrobial treatment concepts for orthopaedic device-related infection. Clin Microbiol Infect 2012;18:1176-84
95. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990;162:96-102
96. Kim BN, Kim ES, Oh MD. Oral antibiotic treatment of staphylococcal bone and joint infections in adults. J Antimicrob Chemother 2014;69:309-22
97. Moran E, Masters S, Berendt AR, et al. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007;55:1-7
98. Bernard L, Legout L, Zurcher-Pfund L, et al. Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty. J Infect 2010;61:125-32
99. Gomez J, Canovas E, Banos V, et al. Linezolid plus rifampin as a salvage therapy in prosthetic joint infections treated without removing the implant. Antimicrob Agents Chemother 2011;55:4308-10
100. Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998;279:1537-41
101. Lora-Tamayo J, Parra-Ruiz J, Rodriguez-Pardo D, et al. High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study. Diagn Microbiol Infect Dis 2014;80:66-71
102. Kusuma SK, Ward J, Jacofsky M, et al. What is the role of serological testing between stages of two-stage reconstruction of the infected prosthetic knee? Clin Orthop Relat Res 2011;469:1002-8
103. Piso RJ, Elke R. Antibiotic treatment can be safely stopped in asymptomatic patients with prosthetic joint infections despite persistent elevated C-reactive protein values. Infection 2010;38:293-6
104. Sendi P, Graber P, Zimmerli W. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin-based regimen. Acta Orthop 2008;79:454
105. Chuard C, Herrmann M, Vaudaux P, et al. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991;35:2611-16
106. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992;14:1251-3
107. El Helou OC, Berbari EF, Lahr BD, et al. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis 2010;29:961-7
108. Senneville E, Joulie D, Legout L, et al. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis 2011;53:334-40
109. Ariza J, Euba G. Murillo O. [Orthopedic device-related infections]. Enferm Infecc Microbiol Clin 2011;26:380-90
110. Murillo O, Domenech A, Garcia A, et al. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2006;50:4011-17
111. Euba G, Murillo O, Fernandez-Sabe N, et al. Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis. Antimicrob Agents Chemother 2009;53: 2672-6
112. Stein A, Bataille JF, Drancourt M, et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998;42: 3086-91
113. Garau J, Bouza E, Chastre J, et al. Management of methicillin-resistant Staphylococcus aureus infections. Clin Microbiol Infect 2009;15:125-36
114. Czekaj J, Dinh A, Moldovan A, et al. Efficacy of a combined oral clindamycin? rifampicin regimen for therapy of staphylococcal osteoarticular infections. Scand J Infect Dis 2011;43:962-7
115. Ferry T, Uçkay I, Vaudaux P, et al. Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infections. Eur J Microbiol Infect Dis 2010;29:171-80
116. El Helou OC, Berbari EF, Marculescu CE, et al. Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clin Infect Dis 2008;47:903-9
117. Murillo O, Domenech A, Euba G, et al. Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection. J Infect 2008;57:229-35
118. Cobo J, Lora-Tamayo J, Euba G, et al. Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria. Diagn Microbiol Infect Dis 2013;76:93-8
119. Clemett D, Markham A. Linezolid. Drugs 2000;59:815-27
120. Murillo O, Garrigos C, Pachon ME, et al. Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009;53: 4252-7
121. Garrigos C, Murillo O, Lora-Tamayo J, et al. Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2012;56:3806-11
122. Garrigos C, Murillo O, Lora-Tamayo J, et al. Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2013;57:606-10
123. John AK, Baldoni D, Haschke M, et al. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 2009;53: 2719-24
124. Garrigos C, Murillo O, Euba G, et al. Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010;54: 5251-6
125. Corona Perez-Cardona PS, Barro Ojeda V, Rodriguez PD, et al. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections. J Antimicrob Chemother 2012;67:1749-54
126. Byren I, Rege S, Campanaro E, et al. Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty. Antimicrob Agents Chemother 2012;56:5626-32
127. Jaen N, Martinez-Pastor JC, Munoz-Mahamud E, et al. Long-term outcome of acute prosthetic joint infections due to gram-negative bacilli treated with retention of prosthesis. Rev Esp Quimioter 2012;25:194-8
128. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 2010;10:43-50
129. Peel TN, Cheng AC, Buising KL, Choong PF. Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother 2012;56: 2386-91
130. Zmistowski B, Fedorka CJ, Sheehan E, et al. Prosthetic joint infection caused by gram-negative organisms. J Arthroplasty 2011;26:104-8
131. Marculescu CE, Cantey JR. Polymicrobial prosthetic joint infections: risk factors and outcome. Clin Orthop Relat Res 2008;466: 1397-404
132. Berbari EF, Marculescu C, Sia I, et al. Culture-negative prosthetic joint infection. Clin Infect Dis 2007;45:1113-19
133. Suda AJ, Kommerell M, Geiss HK, et al. Prosthetic infection: improvement of diagnostic procedures using 16S ribosomal deoxyribonucleic acid polymerase chain reaction. Int Orthop 2013;37:2515-21
134. Moellering RC Jr, Wennersten C. Therapeutic potential of rifampin in enterococcal infections. Rev Infect Dis 1983;5(Suppl 3):S528-32
135. Holmberg A, Morgelin M, Rasmussen M. Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms. J Antimicrob Chemother 2012;67:433-9
136. Euba G, Lora-Tamayo J, Murillo O, et al. Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis. Antimicrob Agents Chemother 2009;53: 4305-10
137. Brouqui P, Rousseau MC, Stein A, et al. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination. Antimicrob Agents Chemother 1995;39:2423-5
138. Legout L, Senneville E, Stern R, et al. Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination. Clin Microbiol Infect 2006;12:1030-3
139. Drapeau CM, Grilli E, Petrosillo N. Rifampicin combined regimens for gram-negative infections: data from the literature. Int J Antimicrob Agents 2010;35: 39-44
140. Morata L, Senneville E, Bernard L, et al. A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention. Infect Dis Ther 2014; 69(Suppl 1):i47-52
141. Pea F, Viale P, Cojutti P, et al. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J Antimicrob Chemother 2012;67:2034-42
142. Pachon-Ibanez ME, Ribes S, Dominguez MA, et al. Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin. Eur J Clin Microbiol Infect Dis 2011;30:89-95
143. Poeppl W, Tobudic S, Lingscheid T, et al. Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model. Antimicrob Agents Chemother 2011;55:4999-5003
144. Martinez-Pastor JC, Vilchez F, Pitart C, et al. Antibiotic resistance in orthopaedic surgery: acute knee prosthetic joint infections due to extended-spectrum betalactamase (ESBL)-producing Enterobacteriaceae. Eur J Clin Microbiol Infect Dis 2010;29:1039-41
145. Lora-Tamayo J, Murillo O, Bergen PJ, et al. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model. J Antimicrob Chemother 2014;69:2434-42
146. Corvec S, Furustrand TU, Betrisey B, et al. Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrumbeta-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother 2013;57:1421-7
147. Samonis G, Maraki S, Karageorgopoulos DE, et al. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis 2012;31:695-701
148. Corvec S, Furustrand TU, Betrisey B, et al. Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrumbeta-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother 2013;57:1421-7
149. de SJ, Teixeira L, van DD, et al. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections. Int J Infect Dis 2014;25:73-8
150. Betsch BY, Eggli S, Siebenrock KA, et al. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 2008;46: 1221-6
151. Puhto AP, Puhto T, Syrjala H. Short-course antibiotics for prosthetic joint infections treated with prosthesis retention. Clin Microbiol Infect 2012;18:1143-8
152. Lopez-Sanchez C, Rodríguez-Pardo D, Pigrau C, et al. Prosthetic Joint Infections due to Enterococcus spp. Which is the Role of Teicoplanin? Presented at the European Bone and Joint Infectious Society Meeting, Utrecht; 2014
153. Benito N, Franco M, Ribera A, et al. Risk Factors for Multi-Drug Resistant Organisms (MDRO) in Prosthetic Joint Infections (PJIs). Poster number 2000. Presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington; 2014
154. Valour F, Karsenty J, Bouaziz A, et al. Antimicrobial-related adverse events during treatment of bone and joint infection due to methicillin susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2014;58:746-55